BRIEF-Fulcrum Therapeutics Q2 Basic EPS USD -0.28

Reuters
Jul 29
BRIEF-<a href="https://laohu8.com/S/FULC">Fulcrum Therapeutics</a> <a href="https://laohu8.com/S/QTWO">Q2</a> Basic EPS USD -0.28

Jul 29 (Reuters) - Fulcrum Therapeutics Q2 net income USD -17.296 million.

  • Q2 operating expenses USD 19.815 million
  • Q2 operating income USD -19.815 million vs. IBES estimate USD -21 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10